Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
OMB No. 0651-0009 (Exp 02/28/2021) |
Serial Number: 88382257 |
Filing Date: 04/11/2019 |
Input Field |
Entered |
SERIAL NUMBER | 88382257 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT17\IMAGEOUT 17\883\822\88382257\xml1\ RFA0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
COLOR MARK | NO |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a two-dimensional triangular figure device. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 500 x 300 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | GlaxoSmithKline Consumer Healthcare (UK) IP Limited |
*STREET | 980 Great West Road |
*CITY | Brentford, Middlesex |
*COUNTRY | England |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
TW89GS |
PHONE | 484-885-9127 |
FAX | 1 215 751 7051 |
EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | limited liability company |
STATE/COUNTRY WHERE LEGALLY ORGANIZED | England |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Analgesics; anti-inflammatory and antipyretic preparations |
FILING BASIS | SECTION 44(e) |
FOREIGN REGISTRATION NUMBER |
005742101 |
FOREIGN REGISTRATION COUNTRY |
European Union Trademark - EUTM |
FOREIGN REGISTRATION DATE |
07/31/2010 |
FOREIGN REGISTRATION EXPIRATION DATE |
03/08/2027 |
DATE FOREIGN REGISTRATION RENEWED (if applicable) |
01/22/2017 |
FOREIGN REGISTRATION FILE NAME(S) | |
ORIGINAL PDF FILE | reg-15251561-192953438_._OPTIZORB_DEVICE_reg.__005742101.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\822\88382257\xml1\RFA0003.JPG |
\\TICRS\EXPORT17\IMAGEOUT17\883\822\88382257\xml1\RFA0004.JPG | |
ORIGINAL PDF FILE | reg-15251561-192953438_._mited_to_GlaxoSmithKline_Consumer_Healthcare__UK__IP_Limited.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\822\88382257\xml1\RFA0005.JPG |
\\TICRS\EXPORT17\IMAGEOUT17\883\822\88382257\xml1\RFA0006.JPG | |
ORIGINAL PDF FILE | reg-15251561-192953438_._renewal_of_EU_OPTIZORB_device.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT17\IMAGEOUT17\883\822\88382257\xml1\RFA0007.JPG |
STANDARD CHARACTERS OR EQUIVALENT |
NO |
ATTORNEY INFORMATION | |
NAME | Terence A Dixon |
ATTORNEY DOCKET NUMBER | 82774088 |
FIRM NAME | GlaxoSmithKline |
INTERNAL ADDRESS | LBP - 3rd floor |
STREET | 5 Crescent Drive |
CITY | Philadelphia |
STATE | Pennsylvania |
COUNTRY | United States |
ZIP/POSTAL CODE | 19112 |
PHONE | 484-885-9127 |
FAX | 1 215 751 7051 |
EMAIL ADDRESS | Trademarks@GSK.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
OTHER APPOINTED ATTORNEY | Christopher M Hanes, Merilee J Arevalo |
CORRESPONDENCE INFORMATION | |
NAME | Terence A Dixon |
FIRM NAME | GlaxoSmithKline |
INTERNAL ADDRESS | LBP - 3rd floor |
STREET | 5 Crescent Drive |
CITY | Philadelphia |
STATE | Pennsylvania |
COUNTRY | United States |
ZIP/POSTAL CODE | 19112 |
PHONE | 484-885-9127 |
FAX | 1 215 751 7051 |
*EMAIL ADDRESS | Trademarks@GSK.com |
*AUTHORIZED TO COMMUNICATE VIA EMAIL | Yes |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS RF |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 275 |
*TOTAL FEE DUE | 275 |
*TOTAL FEE PAID | 275 |
SIGNATURE INFORMATION | |
SIGNATURE | /tad/ |
SIGNATORY'S NAME | Terence A Dixon |
SIGNATORY'S POSITION | Trademark Counsel -member of NY and PA Bar |
SIGNATORY'S PHONE NUMBER | 484-885-9127 |
DATE SIGNED | 04/11/2019 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006) |
OMB No. 0651-0009 (Exp 02/28/2021) |
Serial Number: 88382257 |
Filing Date: 04/11/2019 |
The applicant's current Correspondence Information: |
Terence A Dixon |
GlaxoSmithKline |
LBP - 3rd floor 5 Crescent Drive |
Philadelphia, Pennsylvania 19112 |
484-885-9127(phone) |
1 215 751 7051(fax) |
Trademarks@GSK.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services. |
|
|